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Granzyme B (GZMB) is a proapoptotic serine protease that is released by cytotoxic lymphocytes. However, GZMB can also be
produced by other cell types and is capable of cleaving extracellular matrix (ECM) proteins. GZMB contributes to abdominal
aortic aneurysm (AAA) through an extracellular, perforin-independent mechanism involving ECM cleavage. The murine serine
protease inhibitor, Serpina3n (SA3N), is an extracellular inhibitor of GZMB. In the present study, administration of SA3N was
assessed using a mouse Angiotensin II-induced AAA model. Mice were injected with SA3N (0–120lg/kg) before pump
implantation. A signiﬁcant dose-dependent reduction in the frequency of aortic rupture and death was observed in mice that
received SA3N treatment compared with controls. Reduced degradation of the proteoglycan decorin was observed while
collagen density was increased in the aortas of mice receiving SA3N treatment compared with controls. In vitro studies
conﬁrmed that decorin, which regulates collagen spacing and ﬁbrillogenesis, is cleaved by GZMB and that its cleavage can be
preventedbySA3N.Inconclusion,SA3NinhibitsGZMB-mediateddecorindegradationleadingtoenhancedcollagenremodelling
and reinforcement of the adventitia, thereby reducing the overall rate of rupture and death in a mouse model of AAA.
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Abdominal aortic aneurysms (AAAs) are permanent, focal
dilations of the abdominal aorta and occur in up to 9% of
the population over 65 years.
1 AAA are characterized by
structural deterioration of the aortic wall, loss of elastin,
extensive tissue remodelling, neovascularization and inﬂam-
matory cell inﬁltration.
2,3 The only treatment options for AAA
are open surgical or endovascular repair when the risk of
rupture outweighs the risk of surgery. Given the aging
population, incidence and recent introduction of early screen-
ing programs due to the asymptomatic nature of this disease,
much research is being devoted toward the pursuit
of noninvasive pharmacological approaches to treat small
aneurysms.
4
Granzyme B (GZMB) is a 32kDa serine protease that is
released by cytotoxic lymphocytes.
5 Upon its internalization,
that is facilitated by the pore-forming molecule, perforin,
GZMB proteolyses-speciﬁc intracellular substrates resulting
in apoptotic cell death. However, recently a perforin-
independent, extracellular role for GZMB has been pro-
posed.
6,7 In support of the latter, we have shown, using
apolipoprotein E (ApoE) GZMB-double knockout (GDKO)
and ApoE perforin-double knockout (PDKO) mice, that
GZMB contributes to AAA through an extracellular, perforin-
independent mechanism.
7 GZMB is abundantly expressed in
the adventitia and thrombus of human AAA specimens;
colocalizing to T lymphocytes, mast cells and macrophages
in human aortic aneurysms,
7 thus corroborating the evidence
from the murine model and making GZMB an attractive
therapeutic target for the treatment of AAA.
Decorin is a small chondroitin/dermatan sulfate proteo-
glycan belonging to the family of small leucine-rich proteo-
glycans. In healthy aorta, decorin localizes primarily to
the adventitia, where it interacts extensively with other
extracellular matrix (ECM) proteins and has an important role
in ECM assembly. Decorin is important for collagen organiza-
tion and formation of tight collagen bundles and tensile
strength. Furthermore, decorin-deﬁcient mice exhibit skin
fragility because of reduced collagen tensile strength.
8 In
previous work, we identiﬁed decorin as a substrate of GZMB
and demonstrated that GZMB deﬁciency prevents the loss of
decorin degradation and collagen disorganization in the skin
of aging mice.
6 With respect to aneurysm pathology, deﬁcient
decorin expression is associated with lethal forms of
Marfan’s syndrome
9 and a three-fold downregulation of
decorin expression is observed in patients with acute
aortic dissection.
10
Murine serpina3n (SA3N) is a serine protease inhibitor that
is highly expressed in the brain, testes, spleen, lung and
thymus and has a high degree of homology with the human
a1-antichymotrypsin (ACT). Although in humans there is a
single-gene coding for ACT, in mice, repeated duplication has
resulted in a cluster of 13 closely related genes at the same
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11Ofthese,SA3Nwasfoundtobea potentextracellular
inhibitor of GZMB.
12 Based on our previous results showing
an extracellular role for GZMB in aneurysm pathology,
7 the
purpose of the present study was to determine whether SA3N
could attenuate AAA in mice.
In the current study, SA3N treatment reduced rupture in
Angiotensin II (AII)-treated ApoE-KO mice. As decorin
functions to regulate matrix assembly by modulating collagen
spacing and organization,
13 GZMB likely contributes to the
loss of adventitial collagen architecture through the cleavage
of decorin.
Results
SA3N inhibits murine GZMB activity in vitro.
Preincubation with SA3N dose-dependently inhibited
cleavage of the GZMB tetrapeptide substrate IEPD-pNA
by murine GZMB (Figure 1, IC50¼11.83nM, range 7.925–
17.66nM). These results are consistent with previous results
demonstrating that SA3N inhibits both recombinant human
GZMB and mouse cytotoxic T lymphocyte degranulate
GZMB.
12
SA3N treatment increases 28-day survival and reduces
rate of aneurysm rupture. Necropsy was performed on all
mice that died prematurely before the 28-day time point and
in all cases conﬁrmed the presence of large ruptured aortic
dissections and extensive blood clots in the abdominal
cavity suggesting that death was caused by exsanguination
following AAA rupture. The survival rate of mice that received
a saline sham treatment was 50.0%, whereas serpin
treatment improved survival of mice in a dose-dependent
manner (Figure 2a, SA3N 120mg/kg, n¼9/11, 81.8%; SA3N
40mg/kg, n¼15/18, 83.3%; SA3N 20mg/kg, n¼7/10, 70.0%;
SA3N 4mg/kg, n¼6/11, 54.5%; saline sham, n¼6/12,
50.0%). Log-rank test for trend shows a signiﬁcant increase
in survival with dose of SA3N received (P¼0.0207). Mice
that received 40mg/kg SA3N demonstrated a signiﬁcant
increase in survival when compared with mice that received
sham treatment (Log-rank/Mantel-Cox test, P¼0.0370).
Incidence of aneurysm rupture was reduced from 50.0% in
saline controls to 18.2% in mice that received 120mg/kg
SA3N; 16.7% in those that received 40mg/kg (16.7%); 30.0%
in those that received 20mg/kg; and 45.5% in the group that
received 4mg/kg (Figure 2b).
GZMB immunopositivity corresponds to areas of medial
disruption and reduced decorin. Serial sections of
abdominal aorta from a sham-treated mouse following
aortic rupture were stained for Movat’s Pentachrome
(Figures 3a–c), GZMB (Figures 3d–f) and decorin (Figures
3g–i). Medial GZMB staining (Figure 3f) corresponded to the
region of vessel dilation where profound loss of elastic
lamellae was observed (Figure 3c). The same region exhibits
a marked reduction in decorin (Figure 3i) proximal to the site
of aneurysm. Minimal GZMB staining was noted on the
non-dilated, healthy side of the vessel wall (Figure 3e), which
displayed intact elastic lamellae (Figure 3b) and where
robust decorin (Figure 3h) was observed.
SA3N treatment reduces GZMB immunopositivity. GZMB
was detected in the aortas of ApoE-KO sham-treated mice
(Figures 3 and 4) that developed AAA and particularly elevated
in aneurysms that progressed to rupture. Conversely,
immunodetection of GZMB was reduced in animals receiving
SA3N treatment, particularly, in the adventitia even when small
Figure 1 SA3N inhibits mGZMB enzymatic activity. Mouse GZMB
(20nM)-mediated cleavage of the colorimetric substrate Ac-IEPD-pNA (1mM)
was inhibited by increasing concentrations of SA3N. Percent activity was
determined as the change in initial rate relative to the initial rate in the absence
of SA3N. IC50¼11.83nM (range 7.925–17.66nM). Data represent the mean±
S.E.M of three experiments
Figure 2 GZMB inhibition increases 28-day survival and reduces rate of
aneurysm rupture. (a) Survival. SA3N 120mg/kg (81.8%, n¼11); SA3N 40mg/kg
(83.3%, n¼18); SA3N 20mg/kg (70.0%, n¼10); SA3N 4mg/kg (54.5%, n¼11);
and saline sham (50.0%, n¼12). Log-rank test for trend shows a signiﬁcant
increase in survival with dose of SA3N received (P¼0.0207). (b) Total aneurysm
incidence and rupture. SA3N 120mg/kg (incidence 63.3%; rupture 18.2%);
SA3N 40mg/kg (77.8%; 16.7%); SA3N 20mg/kg (90.0%; 30.0%); SA3N 4mg/kg
(81.8%; 45.5%); saline sham (91.7%; 50.0%)
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Cell Death and Diseaseaneurysms were present (Figure 4). Non-ruptured (NR)
aneurysms with similar pathology from both SA3N- and
sham-treated groups were assessed for immune cell
inﬁltration (CD3-positive T lymphocytes and activated
macrophages); however, no signiﬁcant difference in the
levels of T lymphocytes or macrophages was observed
(data not shown).
SA3N inhibits GZMB-mediated decorin cleavage in vitro.
Active, puriﬁed human GZMB was incubated in vitro with
recombinant human decorin protein. Decorin loss was
observed by western blot (Figure 5a) and cleavage products
were detected by Ponceau staining (Figure 5b). GZMB
incubation resulted in production of numerous cleavage
fragments ranging in size from approximately 15–55kDa.
GZMB-mediated decorin cleavage was abolished in the
presence of SA3N.
SA3N treatment corresponds to increased decorin and
adventitial collagen remodelling. Decorin was markedly
reduced in the adventitial regions of aortas from sham-
treated mice that developed aneurysm (Figure 6i) and
exhibited rupture (Figure 6f) compared with aortas of
healthy animals (Figure 6c). The adventitia surrounding the
thrombus was thin and collagen content was also greatly
reduced (Figures 6d and g). With picrosirius red staining
under polarized light, adventitial collagen ﬁbers from sham-
treated ruptured and NR aneurismal aorta (Figures 6d and g)
appear green and yellow, whereas adventitial collagen ﬁbers
from healthy aorta (Figure 6a) have a higher proportion of
orange and red ﬁbers, indicating higher ﬁber density.
In comparison, the majority of aneurysms observed in the
GDKO and SA3N-treated groups that received the two
highest doses (120 and 40mg/kg) were small aneurysms with
minimal thrombus that did not progress to rupture and
displayed thickened adventitia, increased decorin staining
(Figures 6l and r) and collagen ﬁbers of higher density
(Figures 6j and p) compared with ruptured, sham-treated
aortas. Imaging by second harmonic generation
(SHG) conﬁrmed a reduction in collagen density loss in
SA3N-treated mice compared with the sham-treated groups
(Figure 7). Analysis by one-way analysis of variance
Figure3 GZMBisabundantinvesselsexhibitingmedialdisruption.Serialsectionsofabdominalaortaweretakenfromasham-treatedmousefollowingaorticruptureand
stained for Movat’s Pen/tachrome (4 : a,4 0 : b and c), GZMB (4 : d,4 0 : e and f) and decorin (4 : g,4 0 : h and i). GZMB staining by immunohistochemistry
(d and f)correspondsto regionsof medial disruptionand elastinfragmentation(a andc) andloss of decorinin theadventitia(i). Thenon-dilatedside of theaorta has reduced
GZMB staining in the media and adventitia (d and e) and corresponds to intact elastic lamellae (a and b) and decorin (g and h), scale bars: 4 , 500mm; 40 ,5 0mm
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Cell Death and Diseasedemonstrated a signiﬁcant difference across all groups
(P¼0.0226). SHG signal density representing ﬁber density
was reduced in ruptured and NR sham-treated groups
compared with normal and SA3N-treated mice, however,
only the difference between normal and sham-treated groups
achieved statistical signiﬁcance (sham NR, P¼0.0268;
sham ruptured, P¼0.0218). Notable differences in collagen
architecture and overall appearance were also observed in
sham-treated aneurismal aortas compared with healthy
and SA3N-treated groups, with profound loss of collagen
organization and thick bundle formation.
Discussion
Although once thought to function exclusively as a proapop-
totic, immune-secreted serine protease, GZMB can exert
other perforin- and/or apoptosis-independent roles in patho-
genesis.
14 Indeed, it is now well established that GZMB
accumulates extracellularly in bodily ﬂuids, such as plasma,
synovial ﬂuid, cerebrospinal ﬂuid and bronchoalveolar lavage,
duringconditionsofagingandchronicinﬂammation(reviewed
in Hendel et al.
15). Furthermore, in addition to cytotoxic
lymphocytes, other cell types, both immune and non-immune,
are capable of expressing and secreting this protease alone,
or in combination with perforin, into the extracellular milieu
(reviewed in Hendel et al.
15). GZMB also retains its activity
in plasma
16 and is capable of cleaving ECM in vitro (reviewed
inHendeletal.
15).AsnoextracellularinhibitorsofGZMBhave
been identiﬁed in humans, in addition to being a marker of
inﬂammation, extracellular GZMB activity may contribute to
vascular pathogenesis. Indeed, in human atherosclerosis,
elevated levels of GZMB are associated with increased
disease severity and unstable plaque formation.
17 In further
support of an extracellular role for GZMB in vascular disease,
and of relevance to the present manuscript, GZMB con-
tributes to AII-induced aortic aneurysm in a perforin-indepen-
dent manner.
7 In the latter study, although GDKO mice were
afforded signiﬁcant protection against both progression and
rupture compared with ApoE-KO controls, no protection was
observed in PDKO mice. As this study suggested that
extracellular GZMB was responsible for AAA in part through
the cleavage of ECM, the purpose of the present study was to
determine whether a known murine extracellular inhibitor of
GZMB could elicit a similar effect.
In the present study, SA3N signiﬁcantly improved survival
by reducing adventitial decorin degradation and preventing
aneurysm rupture. SA3N treatment also resulted in a
decrease in overall incidence of aneurysm development that
did not reach signiﬁcance; however, the small unruptured
aneurysms in the 120mg/kg- and 40mg/kg-treated groups
Figure4 GZMBimmunopositivityisreducedinSA3N-treatedmice.GZMBstainingisminimalinhealthyaorta(a)inboththemedia(representedby‘M’)andtheadventitia
(represented by ‘Ad’). GZMB expression is increased particularly in the adventitia of sham-treated mice that experienced rupture (b). Reduced GZMB was observed in
SA3N-treated mice with no AAA (c) and small, remodelled AAA (d), scale bars: 4 , 500mm; 40 ,5 0mm
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Cell Death and Diseasewere morphologically different to those observed in sham-
treated animals. Aneurysms in the sham-treated group
consistently exhibited medial hematomas consistent to that
previously observed by us and others
7,18,19 with a disordered,
ﬁbrous adventitia displaying mostly yellow–green ﬁbers when
stained with picrosirius red, indicating less tightly packed
collagen ﬁbers of smaller diameter. In contrast, aneurysms in
the GDKO and SA3N-treated groups, especially at the higher
doses, demonstrated a remarkable thickening of the adven-
titial layer with red and orange collagen ﬁbers when stained
with picrosirius red. This suggests that the collagen ﬁbers in
the adventitia of these mice exhibited increased thickness,
density and alignment
20 compared with their sham-treated
counterparts. Indeed, when examined by SHG, collagen from
sham-treated groups demonstrated a signiﬁcant reduction in
collagenﬁberdensity andexhibited unidirectional realignment
of ﬁbers, whereas collagen morphology from SA3N-treated
aortas more closely resembled the interwoven network as
seen in healthy controls.
The adventitia is responsible for maintaining the circumfer-
entialstructuralintegrityofthevessel
21anditstensilestrength
is largely reliant on the organization and morphology of its
major constituent, type I collagen.
22 Although medial elastin
loss is a critical factor in aneurysm formation, aneurismal
growth and rupture is dependent on defective collagen
homeostasis.
23 Consistent differences in the optical proper-
ties of aneurismal collagen have been noted when compared
with normal vessels, suggesting a difference in ﬁbril organiza-
tion.
24 Collagen content is both disorganized and reduced in
human aneurysms and dissections of the ascending aorta,
whereas in human AAA, turnover of collagen III is increased
asevidenced byincreasedlevels ofaminoterminal propeptide
of type III collagen and associated with impaired collagen
ﬁbrillogenesis.
25,26 In a study on collagen crosslinking, Carmo
et al.
27 observed an overall decrease in collagen content in
human AAA specimens and concluded that new collagen
synthesis in aneurismal tissues was defective and lacking
proper crosslinking, rendering it more susceptible to proteo-
lytic attack.
Our ﬁndings related to the loss of collagen organization and
packing are consistent with the recent ﬁndings of Lindeman
et al.
28 in which a loss of collagen microarchitecture was
observed in the adventitia of AAA and Marfan syndrome
patients. In the latter, it was proposed that the loose, ribbon-
like appearance of collagen that is observed in a normal
adventitia, but not aneurysmal adventitia, acts as a coherent
networktomaintainmechanicalstrengthandallowsforvessel
dilationandthatthisislostingrowinganeurysms.
28Giventhat
we had also observed a loss of adventitial collagen organiza-
tion in the mouse AAA model, we were interested in how
GZMB might affect this process.
In saline-treated mice with rupture, strong intracellular and
extracellular GZMB staining was apparent in the adventitia
(Figure 4). In contrast, minimal staining was evident in the
serpin-treated groups. Although these results suggest that
serpin administration could lower GZMB levels, it is also very
possible that the non-competitive binding and conformational
change of GZMB within the GZMB–serpin complex results
in reduced recognition and binding of the antibody to
GZMB. Alternatively, it is possible that the non-functional
GZMB–serpin complex may have been cleared from the
vessel. In Figure 3, normal levels of adventitial decorin
staining were observed on the non-dilated side of the vessel
where the elastic lamellae are still intact. Conversely, on the
dilated side where aortic rupture occurred and GZMB staining
was most prominent, decorin staining was nearly absent. We
have previously shown that GZMB degrades decorin in vitro
6
and here we demonstrate that preincubation with SA3N is
capable of preventing cleavage by GZMB (Figure 5). Decorin
stainingwasmarkedlyelevatedinGDKO,furtherimplyingthat
GZMB is responsible for decorin degradation. Decorin
immunopositivity was strong in SA3N-treated mice (Figure 6),
which also displayed reduced levels of GZMB immunoposi-
tivity (Figure 4) in the thickened adventitia compared with
sham controls. GZMB staining was elevated in these sham
controls, particularly when rupture was observed (Figure 4),
whereasdecorinstainingwasnearlydepletedintheadventitia
surrounding the medial thrombus (Figure 6) and at zones
of dilation.
Figure 5 GZMB cleavage of decorin is prevented by pre-incubation with SA3N
in vitro. Puriﬁed GZMB was pre-incubated with or without SA3N for 25min at RT
before incubation with recombinant human decorin for 24h at RT. Proteins were
separated by SDS-PAGE, transferred to a nitrocellulose membrane and visualized
by western blotting for decorin (a) and Ponceau stain (b). In a, full-length decorin is
indicated by an asterisk (*) and is visible at B65kDa in lane 1. Decorin is severely
reduced following incubation with GZMB in lane 2. In lane 3, decorin loss is
not observed following pre-incubation of GZMB with SA3N. In b, SA3N and
SA3N–GZMB complex at approximately 47 and 70kDa, respectively (indicated
by ^) are visible in lanes 2, 3 and 6. Full-length decorin is indicated by the asterisk
(*) at approximately 65kDa in lanes 4, 5 and 6. Decorin cleavage fragments in lane
5 are marked by arrows on the right side of the membrane
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Cell Death and DiseaseBecause collagen is the main structural element of the
adventitia, providing the mechanical and tensile strength, as
well as forming the scaffold for the ECM, the organization and
orientation of the collagen ﬁbrils is critical and largely
determined by interactions with proteoglycans such as
decorin through interﬁbrillar bridges.
29 Decoron, the core
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Cell Death and Diseaseprotein of the decorin molecule, functions as a strong anchor
for the elastic glycan bridge between each decorin molecule
and collagen ﬁbril, conveying elasticity and allowing for
reversible deformation during movement of the vessel wall.
30
Decorin is a key mediator of collagen ﬁbrillogenesis
13,31 and
its incorporation into collagen ﬁbrils improves tensile proper-
ties.
32 Decorin-deﬁcient mice have fragile skin with markedly
reduced tensilestrength.
8,13 Dermal collagen from thesemice
exhibit highly irregular ﬁbril diameter and abnormal ﬁbrillar
organization,
13 suggesting that decorin has a crucial role in
ﬁbril formation, fusion and maintaining stability. Furthermore,
Iwasaki et al.
33 have found that in vitro collagen gels cultured
in the absence of, or with low concentrations of decorin
produced highly porous ﬁber networks with poor elasticity,
whereas gels cultured with higher concentrations of decorin
produced ﬁber networks of signiﬁcantly higher density and
elastic properties. This corroborates our own observation of
higher adventitial collagen ﬁber density in SA3N-treated
animals that also present with correspondingly higher decorin
immunopositivity compared with sham-treated controls. As
furthersupport,wehaverecentlyshownthatdecorincleavage
and loss of collagen ﬁber density are prevented in the skin of
GZMB-deﬁcient mice using a murine model of accelerated
aging.
6
Along with other proteoglycans, decorin can sequester and
regulate the activity of growth factors, such as transforming
growth factor-b,
34 ﬁbroblast growth factor-2,
35 tumor necrosis
factor-a
36 and platelet-derived growth factor,
37 making dec-
orin a critical regulator of numerous receptor-speciﬁc signal-
ling cascades and giving decorin the ability to inﬂuence repair
and remodelling processes in damaged tissues. Under
speciﬁc conditions, decorin binds to the forming collagen
ﬁbrils,functioningasa spacer andslowingdowncollagen ﬁbril
association and fusion. This allows sufﬁcient time for optimal
interactions and crosslinking to occur, and thus forces the
formation of well-organized ﬁbrils of uniform diameter
optimized for local conditions.
13 In the present study, SA3N
treatment reduced decorin cleavage and aneurismal rupture.
Similar observations of adventitial thickening and reduced
loss of decorin were observed in GZMB-deﬁcient mice
suggesting that the cleavage of decorin is most likely due to
GZMB. As further support, SA3N treatment prevented GZMB
cleavage of decorin in vitro. Based on these ﬁndings, we
propose that reducing GZMB in the inﬂammatory milieu
surrounding aneurismal induction facilitates adventitial col-
lagen remodelling by preventing the degradation of decorin,
thereby facilitating decorin-mediated ﬁbrillogenesis and
reinforcement of the adventitia. The vessel thus retains
sufﬁcient tensile strength and ﬂexibility to maintain structural
integrity, constrain dilation and prevent rupture.
In conclusion, we have demonstrated that SA3N improves
survival and reduces the incidence of aneurysm rupture in a
murine model of AAA by preventing decorin degradation and
subsequent collagen disorganization in the adventitia of the
abdominal aorta. We have previously shown that GZMB is
abundantly expressed in human AAA and was colocalized to
numerous immune cell types that are known to have roles in
the pathogenesis of thoracic aortic aneurysm and AAA.
7
AlthoughwedidnotdetectachangeinCD3þ lymphocytesor
macrophages following SA3N treatment compared with NR
sham-treated controls at 28 days post induction, immune cell
inﬁltration is difﬁcult to accurately assess in ruptured aortas in
this model and will require additional study at earlier time
points. We have also previously determined that GZMB
deﬁciency, but not perforin deﬁciency protects against AAA
development in this model.
7 Although this rules out a role for
GZMB/perforin-mediated apoptosis, there is indeed the
possibility that GZMB could be contributing to aneurysm
development through GZMB-mediated anoikis through ECM
cleavage. Indeed, we and others have shown that GZMB
cleavage of ﬁbronectin can result in detachment-induced
death of ﬁbroblasts,
38 endothelial cells
39 and smooth muscle
cells;
40 the loss of which may signiﬁcantly contribute to
aneurysm pathogenesis.
A possible limitation of this current study is that although
SA3N is a potent inhibitor of GZMB, SA3N is also known to
bind and inhibit human leukocyte elastase (neutrophil
elastase),
11 another protease implicated in AAA pathogen-
esis. Leukocyte elastase, however, does not cleave dec-
orin.
41 As elastase-digested aortas are utilized to assess
decorin and biglycan expression in AAA,
41 it is highly unlikely
that inhibition of leukocyte elastase was responsible for
prevention of decorin degradation in this model. This is further
supported by the observation that decorin cleavage is also
prevented in GZMB-deﬁcient mice in the present study.
While the generation of GZMB inhibitors is in progress, at the
present time, no other extracellular inhibitors of mouse
GZMB are available. However, given that SA3N is a potent
inhibitor of GZMB, in combination with the fact that we have
shown that small aneurysms in GDKO and SA3N-treated
mice develop similar morphology and show reduced
propensity to decorin cleavage, adventitial collagen disorga-
nization and rupture, a strong argument can be made for
pursuing further investigations into GZMB as a therapeutic
target for reducing the progression and rupture of aortic
aneurysms.
Figure 6 SA3N and GZMB deﬁciency promotes adventitial thickening and increased decorin content in AAA. Sections stained with picrosirius red are shown in the ﬁrst
column (a, d, g, j, m and p). Tissues immunostained for decorin are shown in the second column (b, e, h, k, n and q) and enlarged for emphasis at 40  in the third column
(c,f,i,l,oandr).Whenstainedwithpicrosiriusred,thickcollagenﬁbersevidencedbystrongbirefringence(red)underpolarizedlight(a)arevisibleintheadventitiaofhealthy
normal aorta, as well as robust decorin staining (b and c). Non-ruptured aneurysms from sham-treated mice exhibit bulbous thrombus, reduced decorin staining (h and i) and
thinnercollagenﬁbersoflowerdensity(g)asevidencedbypredominanceofyellowcolorwhenstainedwithpicrosiriusredandseenunderpolarizedlight.Rupturedaneurysms
from sham-treated mice demonstrate even greater loss of collagen content (d) and a similarly reduced amount of decorin in the adventitia (e and f) compared with healthy
aortas. In comparison, aortas from mice that received SA3N (120mg/kg) before AII pump implantation demonstrate a signiﬁcant increase in collagen and a thickened
adventitiallayer,withagreaterproportionofredandorangeﬁbersunderpolarizedlight(j).Decorincontentintheadventitiaisalsogreatlyincreased(kandl).Morphologyand
levels of collagen and decorin in normal, non-diseased aorta from GDKO mice resemble healthy controls (m, n and o) while GDKO that develop small, localized aneurysm
display thickened adventitia (p) and increased decorin content (q and r) similar to SA3N-treated mice. Scale bars: 4 , 500mm; 40 ,5 0mm
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Murine GZMB enzymatic activity assay: Increasing serpin
concentrations (0.625–80nM) were pre-incubated with active recombinant
mGZMB (20nM, Sigma Aldrich, St. Louis, MO, USA) for 25min in reaction
buffer (50mM HEPES, 10% sucrose, 0.1% CHAPS, 5mM DTT). Cleavage of the
colorimetric GZMB substrate Ac-IEPD-pNA (1mM, Calbiochem, EMD Chemicals,
Gibbstown, NJ, USA) in duplicate reactions was monitored by measuring
absorbance at 405nm using a plate reader (Magellan Tecan SaFire 2, Tecan
GroupLtd.,Ma ¨nnedorf,Switzerland)inkineticmode.Theinitialrateofeachreaction
was calculated, and percent mGZMB activity for each concentration determined
relative to mGZMB activity in the absence of inhibitor. Inhibition was determined in
three separate experiments.
Mice: Allprocedureswereperformedinaccordancewiththeguidelinesforanimal
experimentation approved by the Animal Experimentation Committee of
the University of British Columbia. ApoE-KO mice and GZMB-KO mice (C57Bl/6
background, Stock numbers 002052 and 002248) were obtained from Jackson
Laboratories, Bar Harbor, ME, USA. ApoE GDKO mice were generated by
Figure 7 SA3N treatment reduces the loss of collagen ﬁber density in AII-treated ApoE-KO mice. Adventitial collagen from healthy mouse (a), sham-treated mouse with
ruptured aorta (b), SA3N-treated mouse (c) and sham-treated mouse, non-ruptured (NR) aorta (d) were assessed by SHG. Scale bar: 25mm. SHG signal densities are
summarized in e (n¼3 per group, *Po0.05)
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7
Genotyping was performed using primers and PCR protocols designed by Jackson
Laboratories. All mice were housed at The Genetic Engineered Models facility at
St. Paul’s Hospital, University of British Columbia.
AIIinfusion: Aneurysmwas inducedbyAIIinfusionasdescribedpreviously.
7In
brief, ApoE-KO and GDKO mice aged 11–13 weeks received AII (Sigma Aldrich)
infusion at 1000ng/min/kg for 28 days via micro-osmotic pumps (ALZET model
1004, DURECT Corporation, Cupertino,CA, USA), whichwere surgically implanted
subcutaneously posterior to the scapula.
SA3N treatment: ApoE-KO mice were given a tail vein injection of saline
(sham treatment) (n¼12) or recombinant SA3N diluted in PBS at one of four
doses: 120mg/kg per mouse (n¼11), 40mg/kg per mouse (n¼18), 20mg/kg per
mouse (n¼10) or 4mg/kg per mouse (n¼11) before pump implantation.
Tissue collection and preparation: At 28 days following minipump
implantation, tissues from surviving mice were harvested and aortas characterized
as described previously.
7 Brieﬂy, a gross description of the aorta was made at point of
harvest and these observations were subsequently conﬁrmed by a clinical and
experimental pathologist blinded to treatment type. Necropsies were performed on all
mice that died prematurely before the 28-day time point to determine cause of death.
Tissues were stored in 10% formalin overnight before embedding and sectioning.
Aortic segments were isolated from the abdominal aorta immediately above the renal
arteries. Tissues were embedded in parafﬁn and serial sectioned into 10mms e c t i o n s .
Histological analysis: Abdominal aortic sections were stained with Movat’s
pentachrome and picrosirius red. Immunohistochemistry was performed using
rabbit anti-mouse GZMB (Abcam, Cambridge, MA, USA), goat anti-mouse decorin
(R&D Systems, Minneapolis, MN, USA) as described previously.
6
In vitro decorin cleavage assays
Western blot: Puriﬁed human GZMB (100nM; Axxora, San Diego, CA, USA)
was preincubated with or without recombinant SA3N (240nM) in 50mM Tris buffer,
pH 7.4, for 25min at RT before incubation with recombinant human decorin
(0.16mg; Abnova, Walnut, CA, USA) for 24h at RT. After incubation, proteins
were denatured, separated on a 10% SDS-polyacrylamide gel, transferred to a
nitrocellulose membrane and blocked with 10% skim milk. The membrane was
probed using a mouse anti-human decorin antibody (1:200, R&D Systems) and
IRDye 800 conjugated afﬁnity puriﬁed anti-mouse IgG (1:3000, Rockland Inc.,
Gilbertsville, PA, USA). Bands were imaged using the Odyssey Infrared Imaging
System (LI-COR Biotechnology, Lincoln, NE, USA).
Ponceaustain: PuriﬁedhumanGZMB(80nM;Axxora)waspreincubatedwithor
without recombinant SA3N (240nM) in 50mM Tris buffer, pH 7.4, for 25min at RT
before incubation with recombinant human decorin (0.3mg; Abnova) for 24h at RT.
Afterincubation,proteinsweredenatured,separatedona10%SDS-polyacrylamide
gel and transferred to a nitrocellulose membrane. Ponceau stain was used to
identify cleavage fragments.
Second harmonic generation microscopy and collagen
analysis: Collagen structures in histological specimens were visualized using
SHG microscopy as described previously.
42,43 Ultra-short laser pulse was focused
on the specimen through a Leica 63 /1.2 NA Plan-Apochromat water immersion
objective (Leica Microsystems GmbH, Wetzlar, Germany). SHG signal in the
forward direction originating from the histological specimens was captured using a
non-descanned detector in the transmission geometry. In this non-descanned PMT
detector (R6357, Hamamatsu, Shizuoka, Japan), a 440/20nm band pass ﬁlter
(MP 440/20, Chroma Technology, Bellows Falls, VT, USA) was used to collect
spectrally clean SHG signal. The gain and offset of the PMTs were adjusted for
optimized detection using the color gradient to avoid pixel intensity saturation and
background and these settings kept constant for all measurements. The 3D image
restoration from the collected z-section images was performed using Volocity
software (Improvision, Coventry, UK). For collagen signal density calculations, a
noise removal ﬁlter with kernel size of 3 3 was used to deﬁne the boundary
between foreground and background, and the lower threshold in the histogram was
set to mean voxel intensity value. The total SHG signal intensity values thus
generated were normalized by the total collagen volume (mm
3) and expressed in
arbitrary units (AU).
Data analysis: Statistical analysis was compiled in Graphpad Prism
5 (Graphpad Software, La Jolla, CA, USA). SA3N IC50 concentrations were
determined using nonlinear regression analysis. Survival curves were assessed
usingLog-ranktestfortrendandLog-rank/Mantel-Coxanalysis.AAAincidencewas
assessed by w
2-test for trend across all groups. SHG collagen signal density
was assessed by one-way analysis of variance and unpaired Student’s t-test.
For all tests, signiﬁcant difference was set at Po0.05.
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